Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
作者信息
Kuhn Louise, Sinkala Moses, Kankasa M P H Chipepo, Kasonde Prisca, Thea Donald M, Aldrovandi Grace M
出版信息
J Acquir Immune Defic Syndr. 2006 Jun;42(2):260-2. doi: 10.1097/01.qai.0000214820.26281.df.
Abstract
摘要
相似文献
1
Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.重复使用奈韦拉平预防围产期HIV传播后出现的奈韦拉平耐药病毒突变
J Acquir Immune Defic Syndr. 2006 Jun;42(2):260-2. doi: 10.1097/01.qai.0000214820.26281.df.
2
Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.印度南部接受单剂量奈韦拉平治疗的孕妇中HIV耐药性突变的检测
Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):359-61. doi: 10.4103/0377-4929.81637.
3
Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.对阿比让（科特迪瓦）妇女在单剂量奈韦拉平预防HIV-1母婴传播后奈韦拉平（NVP）耐药突变及HIV-1亚型的特征分析
AIDS Res Hum Retroviruses. 2005 Dec;21(12):1031-4. doi: 10.1089/aid.2005.21.1031.
4
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.单剂量奈韦拉平治疗7天后1型人类免疫缺陷病毒中奈韦拉平耐药性突变的基因连锁
AIDS Res Hum Retroviruses. 2005 Apr;21(4):319-24. doi: 10.1089/aid.2005.21.319.
5
6
Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.分娩期使用替诺福韦和恩曲他滨可降低单剂量奈韦拉平选择的低浓度耐药性，用于预防围产期HIV感染。
AIDS Res Hum Retroviruses. 2009 Nov;25(11):1099-106. doi: 10.1089/aid.2009.0088.
7
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.乌干达女性单剂量奈韦拉平预防用药7天与6 - 8周后奈韦拉平（NVP）耐药性比较：HIVNET 012研究
AIDS Res Hum Retroviruses. 2004 Jun;20(6):595-9. doi: 10.1089/0889222041217518.
8
Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.在乌干达感染1型艾滋病毒的妇女接受奈韦拉平单剂量预防后，其母乳和血浆中的1型艾滋病毒微小耐药性变体
Antivir Ther. 2011;16(1):109-13. doi: 10.3851/IMP1698.
9
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).接受奈韦拉平预防HIV-1垂直传播的妇女和婴儿中耐药突变的选择与消退（HIVNET 012）
AIDS. 2001 Oct 19;15(15):1951-7. doi: 10.1097/00002030-200110190-00006.
10
[Maternal and neonatal drug resistance].[母婴耐药性]
Vopr Virusol. 2011 Sep-Oct;56(5):47-9.
引用本文的文献
1
Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria.尼日利亚乔斯地区1型人类免疫缺陷病毒感染儿童的预处理及获得性耐药性
Open Forum Infect Dis. 2024 Feb 19;11(3):ofae092. doi: 10.1093/ofid/ofae092. eCollection 2024 Mar.
2
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine.儿童在单剂量奈韦拉平暴露后开始抗逆转录病毒治疗时的 HIV-1 耐药性。
AIDS. 2011 Jul 31;25(12):1461-9. doi: 10.1097/QAD.0b013e3283492180.
3
Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: a cohort study.赞比亚卢萨卡地区后续妊娠中重复使用单剂量奈韦拉平预防母婴HIV传播的队列研究
BMC Infect Dis. 2008 Dec 30;8:172. doi: 10.1186/1471-2334-8-172.
4
Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.奈韦拉平预防用药及母乳中HIV-1 RNA抑制对围产期早期HIV-1传播的独立影响。
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):472-8. doi: 10.1097/qai.0b013e3181594c1c.
本文引用的文献
1
Issues in the design of a clinical trial with a behavioral intervention--the Zambia exclusive breast-feeding study.一项行为干预临床试验设计中的问题——赞比亚纯母乳喂养研究
Control Clin Trials. 2004 Aug;25(4):353-65. doi: 10.1016/j.cct.2004.06.005.
2
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.分娩期暴露于奈韦拉平及随后母亲对基于奈韦拉平的抗逆转录病毒疗法的反应。
N Engl J Med. 2004 Jul 15;351(3):229-40. doi: 10.1056/NEJMoa041305. Epub 2004 Jul 9.
3
Low frequency of the V106M mutation among HIV-1 subtype C-infected pregnant women exposed to nevirapine.在暴露于奈韦拉平的感染HIV-1 C亚型的孕妇中，V106M突变的低发生率。
AIDS. 2003 Jul 25;17(11):1698-700. doi: 10.1097/00002030-200307250-00017.
4
Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.围产期HIV-1传播的抗逆转录病毒预防及抗逆转录病毒耐药性的潜在影响。
J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):216-29. doi: 10.1097/00042560-200206010-00011.
5
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).接受奈韦拉平预防HIV-1垂直传播的妇女和婴儿中耐药突变的选择与消退（HIVNET 012）
AIDS. 2001 Oct 19;15(15):1951-7. doi: 10.1097/00002030-200110190-00006.
6
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).1型人类免疫缺陷病毒（HIV-1）亚型对接受单剂量奈韦拉平预防以防止HIV-1垂直传播的女性的影响（HIV预防试验网络012研究）
J Infect Dis. 2001 Oct 1;184(7):914-7. doi: 10.1086/323153. Epub 2001 Aug 13.
Zotero 插件